EUVIMEDEUVIMED entdecken
Open Access

Luteolin enhances drug chemosensitivity by downregulating the FAK/PI3K/AKT pathway in paclitaxel‑resistant esophageal squamous cell carcinoma

Zhenzhen Yang, Hongtao Liu, Yinsen Song, Na Gao, Pan Gao, Yiran Hui, Yueheng Li, Tianli Fan

International Journal of Molecular Medicine · 10.07.2024 · 54 (3)

DOI: 10.3892/ijmm.2024.5401 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Medicine, online erschienen am 10.07.2024. Verfasst von Zhenzhen Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Fifth Clinical Medical College of Henan University of Chinese Medicine (Zhengzhou People's Hospital), Zhengzhou, Henan 450003, P.R. China. Hauptthemen laut MEDLINE: Luteolin, Paclitaxel, Drug Resistance, Neoplasm, Proto-Oncogene Proteins c-akt. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug resistance is a key factor underlying the failure of tumor chemotherapy. It enhances the stem‑like cell properties of cancer cells, tumor metastasis and relapse. Luteolin is a natural flavonoid with strong anti‑tumor effects. However, the mechanism(s) by which luteolin protects against paclitaxel (PTX)‑resistant cancer cell remains to be elucidated. The inhibitory effect of luteolin on the proliferation of EC1/PTX and EC1 cells was detected by cell counting kit‑8 assay. Colony formation and flow cytometry assays were used to assess clonogenic capacity, cell cycle and apoptosis. Wound healing and Transwell invasion tests were used to investigate the effects of luteolin on the migration and invasion of EC1/PTX cells. Western blotting was used to detect the protein levels of EMT‑related proteins and stem cell markers after sphere formation. Parental cells and drug‑resistant cells were screened by high‑throughput sequencing to detect the differential expression of RNA and differential genes. ELISA and western blotting were used to verify the screened PI3K/Akt signaling pathway, key proteins of which were explored by molecular docking. Hematoxylin and eosin staining and TUNEL staining were used to observe tumor xenografts on morphology and apoptosis in nude mice. The present study found that luteolin inhibited tumor resistance (inhibited proliferation, induced cell cycle arrest and apoptosis and hindered migration invasion, EMT and stem cell spherification) in vitro in PTX‑resistant esophageal squamous cell carcinoma (ESCC) cells. In addition, luteolin enhanced drug sensitivity and promoted the apoptosis of drug‑resistant ESCC cells in combination with PTX. Mechanistically, luteolin may inhibit the PI3K/AKT signaling pathway by binding to the active sites of focal adhesion kinase (FAK), Src and AKT. Notably, luteolin lowered the tumorigenic potential of PTX‑resistant ESCC cells but did not show significant toxicity in vivo. Luteolin enhanced drug chemosensitivity by downregulating the FAK/PI3K/AKT pathway in PTX‑resistant ESCC and could be a promising agent for the treatment of PTX‑resistant ESCC cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LuteolinPaclitaxelDrug Resistance, NeoplasmProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesEsophageal Squamous Cell CarcinomaSignal TransductionEsophageal NeoplasmsHumansAnimalsCell Line, TumorMiceMice, NudeCell MovementFocal Adhesion Kinase 1ApoptosisCell ProliferationDown-RegulationMice, Inbred BALB CXenograft Model Antitumor AssaysAntineoplastic Agents, PhytogenicGene Expression Regulation, NeoplasticEpithelial-Mesenchymal TransitionFemaleMale

Stichwörter der Autor:innen

drug chemosensitivityesophageal squamous cell carcinomafocal adhesion kinase/PI3K/AKT pathwayluteolinmolecular docking

Substanzen

LuteolinPaclitaxelProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesFocal Adhesion Kinase 1Antineoplastic Agents, Phytogenic

Autor:innen und Institutionen

  • The Fifth Clinical Medical College of Henan University of Chinese Medicine (Zhengzhou People's Hospital), Zhengzhou, Henan 450003, P.R. China.
  • School of Life Sciences, Zhengzhou University, Zhengzhou, Henan 450001, P.R. China.
  • School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, Henan 450001, P.R. China.

Zitieren

APA

Yang, Z., Liu, H., Song, Y., Gao, N., Gao, P., Hui, Y., Li, Y., & Fan, T. (2024). Luteolin enhances drug chemosensitivity by downregulating the FAK/PI3K/AKT pathway in paclitaxel‑resistant esophageal squamous cell carcinoma. International Journal of Molecular Medicine, 54(3). https://doi.org/10.3892/ijmm.2024.5401

Vancouver

Yang Z, Liu H, Song Y, Gao N, Gao P, Hui Y, et al. Luteolin enhances drug chemosensitivity by downregulating the FAK/PI3K/AKT pathway in paclitaxel‑resistant esophageal squamous cell carcinoma. International Journal of Molecular Medicine. 2024;54(3). doi:10.3892/ijmm.2024.5401

BibTeX
@article{Yang2024,
  author = {Yang, Zhenzhen and Liu, Hongtao and Song, Yinsen and Gao, Na and Gao, Pan and Hui, Yiran and Li, Yueheng and Fan, Tianli},
  title = {Luteolin enhances drug chemosensitivity by downregulating the FAK/PI3K/AKT pathway in paclitaxel‑resistant esophageal squamous cell carcinoma},
  journal = {International Journal of Molecular Medicine},
  year = {2024},
  volume = {54},
  number = {3},
  doi = {10.3892/ijmm.2024.5401}
}
Kostenlos starten →